Moderna is currently encountering difficulties in finding enough young participants for its COVID-19 vaccine trials aimed at adolescents. As the pandemic continues to impact communities, the urgency to vaccinate younger populations has never been greater. Despite the FDA’s recent authorization of the Pfizer-BioNTech vaccine for those aged 16 and 17, Moderna’s vaccine is still only approved for individuals aged 18 and older, as they have not yet completed trials for younger age groups.
The company began its trial targeting 12 to 17-year-olds about a month ago, but they have struggled to secure the necessary 3,000 participants. According to Dr. Emily Carter, a leading researcher in the study, only around 800 volunteers are signing up each month. “It’s crucial for us as a society to understand that we cannot obtain authorization for the vaccine for this age group without the active participation of adolescents,” she stated.
Once sufficient volunteers are recruited, the study will assess the vaccine’s safety and efficacy in adolescents as young as 12. Moderna’s CEO, Alex Thompson, anticipates that the trial could conclude by September. Additionally, plans to initiate a study involving children aged one to 11 are in the pipeline; however, results for this younger demographic may not be available until 2022.
The toll of COVID-19 on children has been significant, with 172 lives lost and many others experiencing severe illness. Although severe cases are less common among teens, they can still transmit the virus to vulnerable populations. Over two million children under 18 were diagnosed with COVID-19 in 2020, highlighting the pandemic’s broader impact on children’s lives, including disruptions to education and activities.
For families considering participation, volunteers will be monitored by medical professionals for 13 months. To learn more about the trial and register, visit this link. Eligible participants must be between 12 and 17 years old, have no prior COVID-19 positive test, and be in good health.
For additional insights, check out our other blog posts, like the one on home insemination kits, which you can find here. Also, if you’re interested in boosting fertility, consider visiting Make a Mom for expert resources. For a comprehensive look at the process of in vitro fertilization, this Wikipedia article serves as an excellent reference.
Search Queries:
- How to enroll children in COVID vaccine trials
- Moderna vaccine trials for teens
- Impact of COVID-19 on children’s health
- Safety of COVID vaccine for adolescents
- Home insemination kit options
Summary:
Moderna is struggling to recruit enough children for its COVID-19 vaccine trial, which aims to include participants aged 12 to 17. Despite the urgency of vaccination, only 800 volunteers are signing up each month, far below the necessary 3,000. The trial’s success is critical for obtaining FDA authorization, especially as the pandemic continues to affect children’s health and well-being. Families interested in participation can find more information and register for the trial.
Keyphrase: “Moderna COVID vaccine trial for children”
Tags: [“home insemination kit”, “home insemination syringe”, “self insemination”]